A phase II trial of temozolomide as a 6-week, continuous, oral schedule in patients with advanced soft tissue sarcoma: a study by the Spanish Group for Research on Sarcomas
Journal article published in 2005 by
Xavier Garcia del Muro,
Xavier Garcia del Muro,
Andres Poveda,
Joan Maurel,
Antonio Lopez-Pousa,
Javier Martin,
Jose M. Buesa,
Antonio Casado,
Javier Martinez-Trufero 
,
Josefina Cruz,
Isabel Bover
,
Josefina Cruz,
Isabel Bover
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 